GO:0106346 snRNA methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106346 (snRNA methyltransferase activity) is a molecular function defined as the catalysis of methyl-group transfer from a donor to a nucleoside residue within an snRNA molecule.
• snRNA methylation is part of the broader RNA methyltransferase landscape that includes m6A and m6Am writers, whose structures and catalytic cores are well characterized.
• RNA modifications such as m6A are deposited across the transcriptome and influence RNA fate, making snRNA methylation relevant to RNA processing and gene regulation.
• Methyltransferase enzymes and their RNA-modifying partners have been linked to cancer, immune evasion and neurological infection models, providing disease contexts for study.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the standard tools for testing whether a candidate methyltransferase is causally required for snRNA methylation.
• Targeted protein relocalization and epitranscriptomic profiling now allow researchers to connect snRNA methyltransferase activity to specific cellular phenotypes.
Description
snRNA methyltransferase activity (GO:0106346) is a molecular function in which an enzyme transfers a methyl group from a donor molecule to a nucleoside residue within a small nuclear RNA (snRNA) molecule. This activity places snRNA methylation within the wider family of RNA methyltransferase reactions that install chemical marks on RNA and thereby expand the information content of the transcriptome. Because snRNAs are core components of the spliceosome and other ribonucleoprotein machines, methylation of their nucleosides can influence RNA structure, RNA-protein interactions and downstream RNA processing events. For researchers, GO:0106346 provides a precise functional annotation to distinguish genuine snRNA-directed methyltransferases from other RNA-modifying enzymes. The catalytic cores of m6A and m6Am RNA methyltransferases have been reviewed in structural detail, revealing conserved methyltransferase folds and donor-binding motifs that inform how snRNA methyltransferases are likely organized. Understanding this activity is therefore important for interpreting epitranscriptomic datasets, for assigning function to uncharacterized methyltransferase-domain proteins, and for designing experiments that test causality between a candidate enzyme and an snRNA methylation event. The biological importance of snRNA methylation is amplified by evidence that RNA-modifying enzymes participate in oncogenic transcription, immune evasion and host-pathogen responses. Although the specific snRNA substrates of many candidate enzymes remain to be mapped, the available literature on RNA methyltransferases provides a robust framework for studying GO:0106346 in normal physiology and disease.
snRNA methyltransferase activity At A Glance
| GO ID | GO:0106346 |
|---|---|
| GO term | snRNA methyltransferase activity |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Major function | Transfer of a methyl group from a donor to a nucleoside residue in an snRNA molecule |
| Substrate | snRNA nucleoside residues |
| Reaction type | Methyl transfer (methylation) |
| Related activities | Other RNA methyltransferase activities such as m6A and m6Am writers |
| Biological context | RNA modification and epitranscriptomic regulation |
What Is GO:0106346?
In our own words, GO:0106346 describes the enzymatic reaction in which a methyl group is moved from a donor (typically S-adenosylmethionine) onto a nucleoside residue of an snRNA molecule. The term captures the catalytic activity itself rather than the downstream consequences of the modification, and it is classified as a molecular_function in the Gene Ontology. It is related to, but distinct from, other RNA methyltransferase activities that act on mRNA, tRNA or rRNA substrates.
Why Is snRNA methyltransferase activity Important in Cell Biology?
GO:0106346 matters because snRNA methylation can alter the structure and function of small nuclear ribonucleoproteins that carry out pre-mRNA splicing and other essential RNA processing steps, and because RNA methyltransferases are increasingly recognized as contributors to cancer, immune regulation and infection biology. Assigning this activity correctly helps researchers separate direct catalytic effects from indirect phenotypes and supports the development of targeted experimental models.
• Defines a specific enzymatic activity that can be used to annotate uncharacterized methyltransferase-domain proteins.
• Connects snRNA biology to the broader epitranscriptomic landscape of m6A and related RNA modifications.
• Provides a functional handle for studying spliceosomal snRNP regulation through chemical modification of snRNA.
• RNA-modifying enzymes have been implicated in oncogenic transcription in acute myeloid leukemia.
• Methylcytosine and related RNA modifications influence glioma immune evasion, showing disease relevance of RNA modification pathways.
• RNA modification enzymes are studied in infertility and nutritional epigenetics contexts.
• NSUN2-mediated RNA methylation promotes gastric cancer progression, illustrating how methyltransferases can drive malignancy.
• Viral infection models such as TBEV-infected neurons reveal pathogenic effectors linked to RNA processing.
• Targeted protein relocalization approaches can be used to probe the spatial regulation of RNA-modifying enzymes.
• CRISPR-based models allow causal testing of candidate snRNA methyltransferase genes in disease-relevant cells.
Molecular Mechanism of snRNA methyltransferase activity
Substrate recognition and snRNA binding
In simple terms: The enzyme first finds and holds the snRNA it is going to modify.
snRNA methyltransferase activity requires the enzyme to recognize a specific snRNA molecule and position the target nucleoside within the active site. Structural studies of m6A and m6Am RNA methyltransferases show that these enzymes use conserved RNA-binding modules and catalytic domains to achieve substrate specificity. The same principles are expected to apply to snRNA-directed methyltransferases, where the RNA target is a small nuclear RNA rather than an mRNA.
Methyl donor binding and catalysis
In simple terms: The enzyme uses a methyl donor to place a methyl group onto the snRNA.
The catalytic step involves binding of a methyl donor, typically S-adenosylmethionine, and transfer of the methyl group to a nucleoside residue in the snRNA. Comprehensive structural reviews of m6A and m6Am methyltransferases describe the conserved methyltransferase fold and the donor-binding pocket that carry out this chemistry. These structural features provide a template for understanding how snRNA methyltransferase activity is executed at the atomic level.
Coupling to RNA processing and RNP assembly
In simple terms: The methylation mark can change how the snRNA works inside the cell.
Because snRNAs are central to spliceosomal and other ribonucleoprotein complexes, methylation of their nucleosides can influence RNA folding, protein recruitment and RNA processing. RNA modifications such as m6A are deposited across the transcriptome and affect RNA fate, supporting the view that snRNA methylation is functionally coupled to RNA processing events. This coupling makes snRNA methyltransferase activity relevant to gene expression regulation beyond the modification reaction itself.
Regulation by interacting proteins and localization
In simple terms: Other proteins and where the enzyme sits in the cell can switch the activity on or off.
RNA methyltransferase activity is often regulated by partner proteins, post-translational modifications and subcellular localization. Targeted protein relocalization studies demonstrate that moving a protein to a new cellular location can change its functional output, a principle that can be applied to RNA-modifying enzymes. In addition, SUMOylation of NSUN2 regulates its function in cancer, illustrating how post-translational modification controls RNA methyltransferase behavior.
Disease-associated rewiring of RNA methylation
In simple terms: In disease, the methylation machinery can be hijacked or misregulated.
RNA modification pathways are frequently rewired in disease. Mutant NPM1 directly regulates oncogenic transcription in acute myeloid leukemia, showing how a nuclear protein can reshape transcriptional and RNA-associated programs. NSUN5/TET2-directed RNA modification governs glioma immune evasion, linking RNA methylation to tumor immunology. These examples support investigating snRNA methyltransferase activity in cancer and immune contexts.
Key Genes Involved in GO:0106346 snRNA methyltransferase activity
The following genes and proteins are representative of the RNA methyltransferase and RNA-modification machinery that provides the biological context for studying snRNA methyltransferase activity (GO:0106346).
| Gene | Major Role | Research Relevance |
|---|---|---|
| METTL3 | Core m6A methyltransferase subunit | Model enzyme for RNA methyltransferase structure and function |
| METTL14 | m6A methyltransferase complex partner | Used to study RNA methyltransferase complex assembly |
| WTAP | m6A complex regulatory subunit | Relevant to methyltransferase complex targeting |
| FTO | m6A/m6Am demethylase | Counteracts RNA methylation marks |
| ALKBH5 | m6A demethylase | Used to study reversible RNA methylation |
| NSUN2 | RNA m5C methyltransferase | SUMOylation regulates its role in gastric cancer |
| NSUN5 | RNA m5C methyltransferase | Linked to glioma immune evasion via TET2 |
| TET2 | 5mC to 5hmC conversion partner | Cooperates with NSUN5 in chromatin-associated RNA modification |
| NPM1 | Nuclear phosphoprotein and transcription regulator | Mutant NPM1 drives oncogenic transcription in AML |
| METTL16 | RNA methyltransferase | Studied as an m6A writer on structured RNAs |
| PCIF1 | m6Am methyltransferase | Provides structural insight into cap-proximal methylation |
| CMTR1 | Cap methyltransferase | Related to RNA cap modification chemistry |
| CMTR2 | Cap methyltransferase | Related to RNA cap modification chemistry |
| TRMT112 | Methyltransferase activator subunit | Common cofactor for RNA methyltransferases |
| FBL | Box C/D snoRNA-associated methyltransferase | Model for RNA-guided methylation |
| DKC1 | Pseudouridine synthase and RNP assembly factor | Links RNA modification to ribonucleoprotein biology |
| NOP58 | snoRNP component | Relevant to RNA-guided modification complexes |
| NHP2 | H/ACA RNP component | Relevant to RNA modification RNP assembly |
How Is snRNA methyltransferase activity Regulated?
snRNA methyltransferase activity is expected to be regulated at several levels, including methyl donor availability, post-translational modification of the enzyme, and interaction with partner proteins that control targeting and stability. SUMOylation of NSUN2 illustrates how post-translational modification can control an RNA methyltransferase and its oncogenic functions. Targeted protein relocalization experiments show that changing a protein's cellular location can alter its activity, providing a general mechanism by which localization regulates RNA-modifying enzymes. In addition, RNA modification pathways intersect with chromatin-associated processes such as NSUN5/TET2-directed 5mC to 5hmC conversion, indicating that regulation can occur through crosstalk with other epigenetic marks.
snRNA methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPM1 | Acute myeloid leukemia oncogenic transcription | CRISPR knock-in of mutant NPM1 in AML cell lines |
| NSUN2 | Gastric cancer progression and m5C methylation | Knockout and overexpression in gastric cancer cells |
| NSUN5/TET2 | Glioma immune evasion | Knockout models in glioma cells and immune co-culture |
| RNA modification machinery | TBEV neuropathogenesis | Infected neuron and astrocyte models with RNA profiling |
| Epigenetic regulators | Male and female infertility | Nutritional and genetic models in reproductive biology |
Cancer and oncogenic transcription
Tumor immune evasion
Infection and neurological disease
Reproductive biology and epigenetics
From snRNA methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for snRNA methylation? | |
| Does a specific catalytic residue mediate methyl transfer? | |
| Does a disease-associated variant alter activity? | |
| Where does the enzyme localize and interact? | |
| Does excess enzyme drive a phenotype? | |
| Which pathways depend on the activity? |
How to Study the snRNA methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA modification profiling | Presence and location of RNA methylation marks | Mapping m6A/m6Am-type marks on RNA |
| RNA-seq | Gene expression and RNA processing changes | Perturbation studies of candidate methyltransferases |
| Integrative RNA profiling | Pathway and effector identification | Infection and disease models |
| Proteomics | Protein interaction partners | Defining methyltransferase complexes |
| Imaging | Subcellular localization of enzymes and RNA | Spatial regulation studies |
| CRISPR knockout | Loss-of-function phenotype | Testing causal requirement for activity |
| CRISPR knock-in | Variant or tag effects | Modeling disease variants and tagging |
| CRISPR library screening | Genome-wide dependency maps | Identifying pathways linked to RNA methylation |
Epitranscriptomic profiling
Transcriptomic and RNA-processing assays
Proteomics and interaction mapping
Imaging and localization
How CRISPR Can Be Used to Study GO:0106346 snRNA methyltransferase activity
Knockout
Point Mutation
Knock-in
Overexpression
How EDITGENE Supports snRNA methyltransferase activity Research
Researchers studying snRNA methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in snRNA methylation, whether a specific catalytic residue is required, and whether disease-associated variants alter the activity. EDITGENE provides the CRISPR cell models and screening services needed to answer these questions with publication-grade rigor.
Contact EDITGENE today to design your custom CRISPR model for snRNA methyltransferase activity research.
Frequently Asked Questions About snRNA methyltransferase activity
What is GO:0106346?
GO:0106346 is the Gene Ontology molecular_function term snRNA methyltransferase activity, defined as catalysis of the transfer of a methyl group from a donor to a nucleoside residue in an snRNA molecule.
What does snRNA methyltransferase activity do?
It transfers a methyl group onto a nucleoside within a small nuclear RNA, potentially altering snRNA structure and its interactions in ribonucleoprotein complexes.
What genes are involved in snRNA methyltransferase activity?
Genes encoding RNA methyltransferases and their partners, such as METTL3, METTL14, WTAP, NSUN2, NSUN5 and related factors, provide the broader context for this activity.
Which diseases are linked to RNA methyltransferase activity?
RNA methyltransferases have been linked to acute myeloid leukemia, gastric cancer, glioma immune evasion and infection-related neuropathology.
How can I study snRNA methyltransferase activity in the lab?
Common approaches include CRISPR knockout, point mutation, knock-in and overexpression models combined with RNA modification profiling, RNA-seq and proteomics.
Is snRNA methylation reversible?
Related RNA methylation marks such as m6A are reversible through demethylases, and structural studies of m6A/m6Am enzymes provide a framework for understanding reversibility.
What is the difference between snRNA methyltransferase activity and m6A methyltransferase activity?
snRNA methyltransferase activity is defined by its snRNA substrate, whereas m6A methyltransferase activity targets adenosine in other RNA contexts; both belong to the broader RNA methyltransferase family.
Why is snRNA methylation important for RNA processing?
snRNAs are core components of spliceosomal and other RNPs, so chemical modification of snRNA nucleosides can influence RNA folding, protein recruitment and processing.
Can CRISPR be used to study snRNA methyltransferase genes?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are standard tools for testing the causal role of candidate methyltransferase genes.
What services does EDITGENE provide for snRNA methyltransferase research?
EDITGENE provides knockout, point-mutation, knock-in and overexpression cell models plus CRISPR library screening and bioinformatics support for RNA modification research.
Conclusion
GO:0106346 snRNA methyltransferase activity defines a specific enzymatic function that connects RNA methylation chemistry to small nuclear RNA biology and downstream RNA processing. Although direct studies of snRNA-specific methyltransferases remain limited, the extensive structural and functional literature on m6A and m6Am RNA methyltransferases provides a strong foundation for mechanistic and disease-oriented research. By combining CRISPR knockout, point-mutation, knock-in and overexpression models with epitranscriptomic profiling and bioinformatics, researchers can test whether candidate enzymes causally mediate snRNA methylation and whether this activity contributes to cancer, immune evasion or infection phenotypes.
References
- 1. Sendinc E et al.. 2023. RNA m6A methylation across the transcriptome.. Mol Cell 83(3):428-441 PMID: 36736310
- 2. Oerum S et al.. 2021. A comprehensive review of m6A/m6Am RNA methyltransferase structures.. Nucleic Acids Res 49(13):7239-7255 PMID: 34023900
- 3. Uckelmann HJ et al.. 2023. Mutant NPM1 Directly Regulates Oncogenic Transcription in Acute Myeloid Leukemia.. Cancer Discov 13(3):746-765 PMID: 36455613
- 4. Ng CSC et al.. 2024. Targeted protein relocalization via protein transport coupling.. Nature 633(8031):941-951 PMID: 39294374
- 5. Wu R et al.. 2024. NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.. Proc Natl Acad Sci U S A 121(14):e2321611121 PMID: 38547058
- 6. Erdoğan K et al.. 2023. Are epigenetic mechanisms and nutrition effective in male and female infertility?. J Nutr Sci 12:e103 PMID: 37771507
- 7. Hu Y et al.. 2021. NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.. Cell Death Dis 12(9):842 PMID: 34504059
- 8. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
